Shares of UnitedHealth Group opened at their lowest point since early 2020 as the health insurance giant's second-quarter ...

Despite strong revenue growth, UnitedHealth's Q2 profitability was impacted by rising healthcare costs. See why I'm ...

UnitedHealth Group Incorporated (NYSE:UNH) is one of the most undervalued blue chip stocks to buy according to hedge funds. J ...

Amid the ongoing UnitedHealth Group (NYSE: UNH) acquisition saga, Amedisys Inc. (Nasdaq: AMED) is seeing continued growth in its home health segment. On ...

CEO Stephen Hemsley expressed optimism despite setbacks with the company’s health services arm and reaffirmed a ...

UnitedHealth Group Incorporated stock is oversold, trading at 12x 2026 profits with a 3.3% dividend yield. Click for more on ...

Hotchkis & Wiley, an investment management company, released its “Hotchkis & Wiley Large Cap Disciplined Value Fund” second-quarter 2025 investor letter. A copy of the letter can be downloaded here.

Q2 2025 Earnings Call Transcript July 29, 2025 UnitedHealth Group Incorporated misses on earnings expectations. Reported EPS ...

One of the companies mentioned in the letter is UnitedHealth Group Inc. (NYSE:UNH). UnitedHealth Group Inc. (NYSE:UNH) ...

UnitedHealth’s (NYSE: UNH) turbulent run in 2025 is escalating after the firm reported disappointing Q2 earnings results.

Returning CEO Stephen Hemsley is lowering expectations, but perhaps not enough.

UnitedHealth Group reported a challenging Q2 with revenue hitting $111.6 billion but EPS faltering at $4.08, missing ...